Spotlight on Trastuzumab Deruxtecan (DS-8201,T-DXd) for HER2 Mutation Positive Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Spotlight on Trastuzumab Deruxtecan (DS-8201,T-DXd) for HER2 Mutation Positive Non-Small Cell Lung Cancer

Published:2021-10 Issue: Volume:Volume 12 Page:103-114
ISSN:1179-2728
Container-title:Lung Cancer: Targets and Therapy
language:en
Short-container-title:LCTT

Author:

Azar Ibrahim^ORCID,Alkassis Samer,Fukui Jami,Alsawah Fares,Fedak Kalub,Al Hallak Mohammed Najeeb,Sukari Ammar^ORCID,Nagasaka Misako^ORCID

Publisher

Informa UK Limited

Subject

Oncology

Reference68 articles.

1. Amplification of a Novel v- erb B-Related Gene in a Human Mammary Carcinoma

2. The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors

3. c-erbB-2 Related Aggressiveness in Breast Cancer Is Hypoxia Inducible Factor-1α Dependent

4. Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor

5. Targeted Disruption of Mouse EGF receptor: Effect of Genetic Background on Mutant Phenotype

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spotlight on the treatment of non‐small cell lung cancer with rare genetic alterations and brain metastasis: Current status and future perspectives;International Journal of Cancer;2024-07-03

2. The Evolving Paradigm of Antibody–Drug Conjugates Targeting the ErbB/HER Family of Receptor Tyrosine Kinases;Pharmaceutics;2024-07-02

3. Prognostic Significance of Pan-Immune-Inflammation Value in Patients with HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine;Pharmaceuticals;2024-06-23

4. UGT1A1 Testing in Breast Cancer: should it become routine practice in patients treated with antibody-drug conjugates?;Critical Reviews in Oncology/Hematology;2024-04

5. Pioneering the Way: The Revolutionary Potential of Antibody–Drug Conjugates in NSCLC;Current Treatment Options in Oncology;2024-03-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3